These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The first examples of mRNA cap analogs bearing boranophosphate modification. Kowalska J; Zuberek J; Darzynkiewicz ZM; Lukaszewicz M; Darzynkiewicz E; Jemielity J Nucleic Acids Symp Ser (Oxf); 2008; (52):289-90. PubMed ID: 18776367 [TBL] [Abstract][Full Text] [Related]
9. Phosphorothioate analogs of m7GTP are enzymatically stable inhibitors of cap-dependent translation. Kowalska J; Lukaszewicz M; Zuberek J; Ziemniak M; Darzynkiewicz E; Jemielity J Bioorg Med Chem Lett; 2009 Apr; 19(7):1921-5. PubMed ID: 19269171 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of anti-reverse cap analogs (ARCAs) and their applications in mRNA translation and stability. Grudzien-Nogalska E; Stepinski J; Jemielity J; Zuberek J; Stolarski R; Rhoads RE; Darzynkiewicz E Methods Enzymol; 2007; 431():203-27. PubMed ID: 17923237 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and characterization of mRNA cap analogs containing phosphorothioate substitutions that bind tightly to eIF4E and are resistant to the decapping pyrophosphatase DcpS. Kowalska J; Lewdorowicz M; Zuberek J; Grudzien-Nogalska E; Bojarska E; Stepinski J; Rhoads RE; Darzynkiewicz E; Davis RE; Jemielity J RNA; 2008 Jun; 14(6):1119-31. PubMed ID: 18430890 [TBL] [Abstract][Full Text] [Related]
12. High affinity RNA for mammalian initiation factor 4E interferes with mRNA-cap binding and inhibits translation. Mochizuki K; Oguro A; Ohtsu T; Sonenberg N; Nakamura Y RNA; 2005 Jan; 11(1):77-89. PubMed ID: 15611299 [TBL] [Abstract][Full Text] [Related]
13. m7GTP alphaS is a strong and stable inhibitor of cap-dependent translation. Kowalska J; Lukaszewicz M; Zuberek J; Ziemniak M; Strenkowska M; Darzynkiewicz E; Jemielity J Nucleic Acids Symp Ser (Oxf); 2008; (52):291-2. PubMed ID: 18776368 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of Leishmania cap-4 intermediates, cap-2 and cap-3. Lewdorowicz M; Stepinski J; Kierzek R; Jemielity J; Zuberek J; Yoffe Y; Shapira M; Stolarski R; Darzynkiewicz E Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1339-48. PubMed ID: 18066780 [TBL] [Abstract][Full Text] [Related]
15. Thermodynamic analysis of mRNA cap binding by the human initiation factor eIF4E via free energy perturbations. Guimarães CR; Kopecky DJ; Mihalic J; Shen S; Jeffries S; Thibault ST; Chen X; Walker N; Cardozo M J Am Chem Soc; 2009 Dec; 131(50):18139-46. PubMed ID: 19924990 [TBL] [Abstract][Full Text] [Related]
16. Structural changes of eIF4E upon binding to the mRNA 5' monomethylguanosine and trimethylguanosine Cap. Rutkowska-Wlodarczyk I; Stepinski J; Dadlez M; Darzynkiewicz E; Stolarski R; Niedzwiecka A Biochemistry; 2008 Mar; 47(9):2710-20. PubMed ID: 18220364 [TBL] [Abstract][Full Text] [Related]
17. Dinucleotide cap analogue affinity resins for purification of proteins that specifically recognize the 5' end of mRNA. Jankowska-Anyszka M; Piecyk K Bioorg Med Chem Lett; 2011 Oct; 21(20):6131-4. PubMed ID: 21889340 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of potential inhibitors of eIF4E cap binding to 7-methyl GTP. Ghosh P; Park C; Peterson MS; Bitterman PB; Polunovsky VA; Wagner CR Bioorg Med Chem Lett; 2005 Apr; 15(8):2177-80. PubMed ID: 15808492 [TBL] [Abstract][Full Text] [Related]
19. Affinity of dinucleotide cap analogues for human decapping scavenger (hDcpS). Darzynkiewicz ZM; Bojarska E; Stepinski J; Jemielity J; Jankowska-Anyszka M; Davis RE; Darzynkiewicz E Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1349-52. PubMed ID: 18066781 [TBL] [Abstract][Full Text] [Related]
20. Crystallographic and mass spectrometric characterisation of eIF4E with N7-alkylated cap derivatives. Brown CJ; McNae I; Fischer PM; Walkinshaw MD J Mol Biol; 2007 Sep; 372(1):7-15. PubMed ID: 17631896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]